Healthcare
BioMed Partners and HTGF lead €10.7m round for Tubulis
Seventure Partners, Coparion, Bayern Kapital and Occident also back the pharmaceutical company
BIVF et al. back CHF 25m round for T3 Pharmaceuticals
Reference Capital and multi-family office Wille Finance also backed the cancer therapy developer
CVC buys Italian pharma company Genetic
GP deploys capital from CVC Strategic Opportunities II, which held a final close on €4.6bn in July 2019
Auctus-backed PharmaLex buys Regulis Consulting
Deal is the consultancy's second bolt-on in 2020; it expects to generate 2020 revenues of €120m
Cathay Capital leads €30m round for Biose
Company intends to use the fresh capital to strengthen its market position, and expand in the US and China
Novo Holdings et al. in $20m round for Reapplix
Company will use the proceeds to commercialise its flagship product across the US
Elige Capital, Extens invest in Medireport
Company intends to use the fresh capital to consolidate its market position in France and boost its expansion
Kester-backed Frontier sells business to HIG-backed Vernacare
HIG invested from its Growth Buyout Equity Fund III to acquire Vernacare from Palatine
Blackstone Life Sciences V closes on $4.6bn
Fund invests in late-stage rounds of established life science companies and emerging businesses
Great Point’s MLM Medical Labs buys CirQuest
Acquisition of US-based laboratory services provider is part of MLM's international expansion strategy
Mercia sells NAC to PE-backed LGC for £18m
Mercia held a 29.4% stake in NAC at the date of sale and will receive initial cash proceeds of £4.8m
Forbion holds first close for Growth Opportunities Fund
New strategy focuses on pre-IPO capital and capital for undervalued listed life sciences companies
Osivax raises €33m from EIC and BPI France
Of the funding, €15m from EIC will count towards series-B funding, while the rest will be a grant
Alta Life Sciences, Kurma lead €3.5m series-A for Deepull
Axis Participaciones and Sofimac Innovation, through Pertinence Invest 2, also take part in the round
Triton's Meine Radiologie buys three gynaecology clinics
Clinics will operate under MVZ Meine Gynäkologie Lüdenscheid, a Meine Radiologie Holding subsidiary
Tar Heel buys 70% stake in Estetique
GP is looking to create a nationwide dental group and intends to sell it in five to seven years to an industry investor
Seventure, BioGeneration lead €18.5m round for Citryll
Pharma company has so far raised €33.5m from private backers
Creas leads €3.6m round for Qida
Equity4Good, a vehicle managed by Ship2B, and Fondo Bolsa Social also take part in the round
Freeline closes $120m extended series-C round
Financing augments Syncona's previously announced series-C investment in Freeline of $40m
Donau Invest backs Curasan restructuring
Pharmaceutical company will be delisted and acquired by Donau Invest, subject to creditor agreement
Omnes, Principia, Seventure in €46.3m series-E for Enterome
New investors SymBiosis and Takeda Pharmaceutical Company also take part in the round
Longitude Capital leads $40m round for Polares Medical
Existing investors Decheng, Endeavour Vision, IDO, Earlybird and Wellington also take part
WestBridge invests £9.6m in BHSC
BHSC reported revenue of £14.5m and an operating profit of £2m for the 2019 financial year
Trilantic's Doppel bolts on Dietopack
Trilantic Europe said in a statement that its healthcare companies have made seven bolt-ons in 2020